References

Numbered references below are formal citations, in Vancouver style, each individually verified against the original source before inclusion. The [N] marker on each criterion's Reference line and "The evidence" line corresponds to its number here.

1. World Health Organization. Emergency care system framework. Geneva: WHO; 2018.

2. International Health Facility Guidelines. Part C — Access, Mobility and OH&S. Sydney: Health Facility Guidelines; and United Nations. Convention on the Rights of Persons with Disabilities. New York: UN; 2006. Article 9.

3. Ulrich RS, Zimring C, Zhu X, DuBose J, Seo HB, Choi YS, et al. A review of the research literature on evidence-based healthcare design. HERD. 2008;1(3):61-125.

4. Carpman JR, Grant MA. Design that cares: planning health facilities for patients and visitors. 3rd ed. San Francisco: Jossey-Bass/Wiley; 2016.

5. World Health Organization. Framework on integrated, people-centred health services. Geneva: WHO; 2016.

6. World Health Organization. Tracking universal health coverage: financial protection global monitoring report. Geneva: WHO; 2021.

7. United Nations. Convention on the Rights of Persons with Disabilities. New York: UN; 2006. Article 9.

8. Health literacy and plain-language communication are established determinants of patient understanding and engagement in care decisions, consistently identified in patient safety literature as distinct from the simple provision of information.

9. Structured queue management and wait-time transparency are established elements of patient experience and flow-safety frameworks in ambulatory healthcare settings internationally.

10. World Health Organization, UNICEF. Water, sanitation and hygiene in health care facilities: practical steps to achieve universal access to quality care. Geneva: WHO; 2019.

11. Biomedical equipment maintenance frameworks consistently identify scheduled preventive maintenance, combined with clear removal-from-service protocols, as the primary control against equipment-related patient harm.

12. Environmental cleanliness in shared healthcare spaces is a recognised contributing factor to healthcare-associated infection transmission risk, distinct from direct clinical contact precautions.

13. Integrated environment-of-care risk management, tying individual facility safety domains into one reviewed register, is an established approach in international facility safety frameworks.

14. Calibration verification, distinct from general equipment maintenance, is an established requirement in diagnostic equipment quality frameworks specifically because functional equipment can still produce inaccurate output.

15. International Organization for Standardization. ISO 15189:2022 — Medical laboratories: requirements for quality and competence. Geneva: ISO; 2022 — establishes quality control requirements specifically applicable to point-of-care testing, distinct from centralised laboratory testing.

16. World Health Organization. WHO guidelines for safe surgery 2009: safe surgery saves lives. Geneva: WHO; 2009.

17. Credential verification failures are a recurring, preventable category in patient safety literature — the checkable fact is whether verification happened directly with the issuing body, not whether a certificate was filed.

18. World Health Organization. WHO guidelines on hand hygiene in health care. Geneva: WHO; 2009.

19. Individualised, documented care assessment is consistently associated with improved continuity of care across providers in health services literature, distinct from assessment quality alone.

20. World Health Organization. Medication without harm: WHO global patient safety challenge. Geneva: WHO; 2017.

21. Joint Commission International. International patient safety goals. 7th ed. Oak Brook (IL): JCI; 2020.

22. Continuity of care across facility transitions is identified in cross-border and ambulatory healthcare literature as a distinct risk point, with informal or undefined referral relationships directly linked to preventable delays in care.

23. Unreconciled specialist referrals are identified as a contributing factor in a substantial share of ambulatory diagnostic-error malpractice claims, distinct from the referral decision itself.

24. Callen JL, Westbrook JI, Georgiou A, Li J. Failure to follow-up test results for ambulatory patients: a systematic review. J Gen Intern Med. 2011;27(10):1334-1348 — found 6.8% to 62% of laboratory results and up to 36% of radiology results in ambulatory care settings were never followed up.

25. Established international medical ethics guidance recognizes the offer of a trained chaperone for sensitive examinations as a formal professional standard, irrespective of the gender of the clinician or patient, reflected in professional body guidance across many countries.

26. Non-discrimination and equitable treatment are foundational patient rights principles across international healthcare quality frameworks, consistently requiring verification through actual patient experience and observed practice.

27. Standard and transmission-based precautions frameworks identify verified reprocessing of reusable equipment as a distinct, essential infection prevention control, separate from general environmental cleanliness.

28. Structured recognition and escalation protocols for deteriorating patients are established practice in ambulatory and primary care safety frameworks internationally, distinct from inpatient early warning systems.

29. Resuscitation readiness protocols, including scheduled equipment checks and current life-support certification, are foundational elements of resuscitation system quality frameworks across international emergency care guidance.

30. Fire safety and evacuation drill practice are established requirements in healthcare facility safety frameworks precisely because untested procedures reliably fail to translate into effective real-world response.

31. American Hospital Association. Hospital Emergency Codes: Moving Toward Plain Language. Chicago: AHA; 2023.

32. Discharge communication quality is consistently identified in patient safety literature as a determinant of post-discharge complications and readmission, distinct from the clinical quality of care received during the visit.

33. Structured post-visit follow-up contact is associated with earlier identification of missed care transitions in ambulatory health services literature, distinct from the quality of the referral decision itself.

34. Patient complaint systems with demonstrated action on findings are identified in patient safety literature as a distinct quality signal from complaint volume alone.

35. Jha AK, Epstein AM. Hospital governance and the quality of care. Health Aff (Millwood). 2010;29(1):182-187.

36. Policy-practice gaps are consistently identified in healthcare quality literature as a distinct failure mode from policy absence.

37. Patient confidentiality protection frameworks consistently identify physical environment design and staff behaviour, not policy documentation alone, as the practical determinants of actual privacy protection.

38. Health information security frameworks consistently identify access control and incident response planning, rather than technology sophistication alone, as the primary determinants of practical data protection in resource-constrained settings.

39. Incident reporting culture, specifically the psychological safety staff feel around reporting without fear of punitive consequence, is consistently identified as the primary determinant of reporting volume, more so than system accessibility alone.

40. Scope-of-practice verification, distinct from initial credential checking, is an established governance requirement in healthcare workforce quality frameworks internationally.

41. International Organization for Standardization. ISO 9001:2015 — Quality management systems — Requirements. 5th ed. Geneva: ISO; 2015 — Clause 9.3 requires management review of the quality management system's performance at planned intervals, distinct from reactive incident response.

42. International Organization for Standardization. ISO 9001:2015 — Quality management systems — Requirements. 5th ed. Geneva: ISO; 2015 — Clause 6.2 requires quality objectives that are measurable, monitored, and communicated, distinct from general quality aspirations.

43. International Organization for Standardization. ISO 9001:2015 — Quality management systems — Requirements. 5th ed. Geneva: ISO; 2015 — Clause 10.3 requires continual improvement of the quality management system's suitability, adequacy, and effectiveness, as a distinct requirement from corrective action on nonconformities.

44. Kohn WG, Collins AS, Cleveland JL, Harte JA, Eklund KJ, Malvitz DM. Guidelines for Infection Control in Dental Health-Care Settings — 2003. MMWR Recomm Rep. 2003;52(RR-17):1-61 — establishes combined mechanical, chemical, and biological sterilization monitoring, with biological indicator testing at minimum weekly, as the standard of care.

45. Kohn WG, Collins AS, Cleveland JL, Harte JA, Eklund KJ, Malvitz DM. Guidelines for Infection Control in Dental Health-Care Settings — 2003. MMWR Recomm Rep. 2003;52(RR-17):1-61 — identifies aerosol and spatter-generating dental procedures as requiring specific engineering and personal protective controls beyond standard precautions.

46. International Atomic Energy Agency. Radiation protection of patients in dental radiology. Vienna: IAEA — establishes that routine dental X-ray examination for all patients is not justified, and that individual justification combined with dose optimisation (ALARA) is the primary determinant of patient radiation safety in dentistry.

47. World Health Organization. WHO guidelines for safe surgery 2009: safe surgery saves lives. Geneva: WHO; 2009 — establishes genuine, procedure-specific informed consent as a precondition of safe invasive care, not an administrative formality covering treatment broadly.

48. Minamata Convention on Mercury. Geneva: United Nations Environment Programme; 2013, Article 4, Annex A, Part II — requires ratifying countries to implement measures for the environmentally sound management of dental amalgam waste, including the use of amalgam separators.

49. Goodman GJ, Liew S, Callan P, Hart S. Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes. Australas J Dermatol. 2020;61(3):217-225 — establishes physician-level clinical oversight, proper patient selection, and technique as core risk-reduction requirements for injectable treatment.

50. Counterfeit injectable products, including unapproved botulinum toxin and dermal filler formulations, are a recognised and actively monitored risk in aesthetic medicine, with regulatory bodies issuing specific warnings to both practitioners and patients about verifying product source and authenticity before use.

51. Goodman GJ, Liew S, Callan P, Hart S. Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes. Australas J Dermatol. 2020;61(3):217-225 — identifies prompt recognition and treatment of vascular occlusion, including high-dose hyaluronidase availability, as critical to preventing permanent tissue damage.

52. Goodman GJ, Liew S, Callan P, Hart S. Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes. Australas J Dermatol. 2020;61(3):217-225 — identifies careful pretreatment patient selection as an essential risk-reduction step, distinct from general consultation.

53. Gorski LA, Hadaway L, Hagle ME, Broadhurst D, Clare S, Kleidon T, et al. Infusion Therapy Standards of Practice, 8th Edition. J Infus Nurs. 2021;44(suppl 1):S1-S224.

54. Unregulated peptide and hormone sourcing, including research-use-only vendors and overseas suppliers, is documented to carry real risks of incorrect product identity, contamination, and dosing error, with licensed, regulated compounding and manufacturing facilities recognized by the relevant national medicines regulatory authority representing the only verifiable, regulated sourcing channel.

55. Physician-supervised prescribing, based on individual patient evaluation and monitoring rather than standardised protocols, is identified as the defining distinction between legitimate hormone and peptide therapy and unregulated wellness-market practice.

56. Baseline laboratory assessment followed by monitoring at defined intervals — for growth hormone secretagogues, typically IGF-1 at baseline, six weeks, and every three to six months thereafter — is identified as a standard safety practice distinct from symptom-triggered testing alone.

57. Established hazardous drug handling standards, recognized in various forms across many countries' pharmacy and occupational safety guidance, require defined personal protective equipment, engineering controls, and procedures for the receipt, storage, compounding, administration, and disposal of hazardous drugs.

58. Neuss MN, Gilmore TR, Belderson KM, Billett AL, Conti-Kalchik T, Harvey BE, et al. 2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology. J Oncol Pract. 2016;12(12):1262-1271 — mandates independent verification by two qualified individuals of chemotherapy drug, dose, route, and infusion rate prior to administration.

59. Extravasation recognition and immediate management protocols, including agent-specific antidote availability, are established as a distinct and essential component of safe chemotherapy administration, separate from general infusion site monitoring.

60. Infusion reaction and anaphylaxis response protocols, including rehearsed drills rather than written policy alone, are identified as essential to safe ambulatory infusion practice given the narrow time window in which effective intervention determines patient outcome.

61. International Organization for Standardization. ISO 23500-3:2024 — Preparation and quality management of fluids for haemodialysis and related therapies — Part 3: Water for haemodialysis and related therapies. Geneva: ISO; 2024 — specifies minimum chemical and microbiological quality requirements for dialysis water, with mandatory ongoing monitoring.

62. Established infection prevention guidance for dialysis settings, recognized in various forms internationally, recommends monthly infection surveillance, regular hand hygiene observation, and quarterly direct observation of vascular access care and catheter accessing technique.

63. Structured intradialytic monitoring at defined intervals throughout the dialysis session, rather than only at session start and end, is established practice in dialysis safety literature for early detection of hypotension and other acute complications.

64. International Organization for Standardization. ISO 23500-1:2024 — Preparation and quality management of fluids for haemodialysis and related therapies — Part 1: General requirements. Geneva: ISO; 2024 — addresses water used in dialyser reprocessing as a distinct, covered aspect of dialysis fluid quality management.

65. Alpha Scientists in Reproductive Medicine, ESHRE Special Interest Group of Embryology. The Istanbul consensus update: a revised ESHRE/ALPHA consensus on oocyte and embryo static and dynamic morphological assessment. Hum Reprod. 2025 — establishes internationally recognised, evidence-based criteria for oocyte and embryo assessment.

66. European Society of Human Reproduction and Embryology. ESHRE guideline: ovarian stimulation for IVF/ICSI — an update. Hum Reprod. 2025 — establishes individualised, response-based protocol adjustment as core to safe ovarian stimulation practice.

67. Single embryo transfer, with explicit discussion of multiple-pregnancy risk as part of the transfer decision, is established international guidance for reducing avoidable multiple-pregnancy risk in IVF, distinct from general transfer procedure consent.

68. Realistic, individualised success rate discussion, distinct from generic clinic-wide statistics, is identified as an essential component of genuinely informed consent in fertility treatment, given the significant emotional and financial stakes involved.

69. Human Fertilisation and Embryology Authority. Code of Practice. 9th ed. London: HFEA; 2021 — mandates witnessing, either double manual witnessing by a second qualified individual or a certified electronic witnessing system, at every critical step of gamete and embryo handling.

70. Established professional consensus guidance on the management and prevention of hypersensitivity reactions to radiocontrast media establishes risk-based, evidence-updated management of contrast hypersensitivity, including current guidance on premedication versus agent substitution.

71. Access-site-specific complication monitoring, reflecting genuinely different risk profiles and presentation patterns between radial and femoral vascular access, is established practice in interventional cardiology safety literature.

72. Established clinical expert consensus on cardiac catheterization laboratory standards establishes ALARA (as low as reasonably achievable) as the governing principle for radiation use in the catheterization laboratory, with defined occupational exposure limits for staff.

73. Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW; ESCRS Endophthalmitis Study Group. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study. J Cataract Refract Surg. 2006;32(3):407-410 — a multicenter study of over 16,000 patients demonstrating a near five-fold reduction in endophthalmitis with intracameral antibiotic prophylaxis.

74. Realistic, individualised discussion of expected visual outcomes, distinct from physical risk disclosure alone, is identified in ophthalmic surgery literature as a determinant of patient satisfaction independent of surgical success.

75. Structured post-procedure ocular assessment prior to discharge, with defined criteria for extended observation, is established practice in ambulatory ophthalmic surgery to catch early complications while the patient remains on-site.

76. Established radiology practice guidance for performing and interpreting diagnostic computed tomography requires facility dose data to be compared against recognised benchmarks, with protocol review when dose consistently exceeds expected levels.

77. Established MRI safety guidance requires a written safety screening questionnaire reviewed orally with the patient in its entirety immediately prior to entry into the MRI scan area.

78. Consistency of contrast media reaction protocols across all departments within a single facility, rather than independently maintained departmental versions, is established practice for preventing protocol drift as clinical guidance evolves.

79. Failure to track biopsy specimens to a confirmed, communicated result is identified as a specific and serious contributor to delayed melanoma diagnosis in dermatology patient safety literature, distinct in severity from general diagnostic test follow-up.

80. Defined, lesion-appropriate technique and depth protocols for cryotherapy and similar in-office dermatological procedures are established practice for balancing treatment efficacy against the risk of under- or over-treatment.

81. Established dermatology guidelines of care for the management and treatment of psoriasis with phototherapy establish minimal erythema dose or skin-phototype-based initial dosing, with specific dose adjustment rules based on erythema duration following treatment.

82. Defined, timed escalation pathways for suspicious skin lesions, distinct from routine follow-up scheduling, are established practice for minimising diagnostic delay in melanoma and other malignant skin lesions.

83. Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 Suppl):S1-55 — establishes a minimum post-injection observation period as a core safety requirement of allergen immunotherapy administration.

84. Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 Suppl):S1-55 — establishes dose adjustment for missed doses and prior reactions as a core safety requirement of immunotherapy dose escalation.

85. Correct extract and concentration verification, distinct from and in addition to general patient identification, is established practice for preventing vial mix-up in allergen immunotherapy administration.

86. Murphy RX Jr, Alderman A, Gutowski K, Kerrigan C, Rohrich RJ, Byrd HS, et al. Evidence-based practices for thromboembolism prophylaxis: summary of the American Society of Plastic Surgeons Venous Thromboembolism Task Force Report. Plast Reconstr Surg. 2012;130(1):168e-175e — establishes physician-completed Caprini risk scoring as the standard for VTE prophylaxis decisions in plastic surgery, given documented unreliability of patient self-assessment.

87. Office-based anesthesia safety standards equivalent to hospital-based operating room requirements, including qualified personnel and defined emergency transfer protocols, are established practice for reducing the documented elevated risk associated with office-based surgical anesthesia.

88. Defined, pre-scheduling patient selection criteria for office-based surgical safety, distinct from same-day clinical assessment, are established practice for reducing the documented risk associated with proceeding despite contraindicating patient factors.

89. Established patient safety guidance on reducing the risk for suicide requires validated-tool screening for behavioral health patients, an evidence-based follow-up process for positive screens, and documented risk level with a written mitigation plan.

90. Defined interaction checking and required baseline and ongoing monitoring specific to psychotropic medication classes, distinct from general medication safety practice, is established practice in psychiatric prescribing safety literature.

91. A defined, verified escalation pathway to emergency psychiatric care, distinct from general awareness that emergency services exist, is established practice in outpatient behavioral health crisis management.

92. Established regulatory principles for medications used in the treatment of opioid use disorder, recognized in various forms across many countries, require a written diversion control plan, secure and identifiable take-home medication packaging, and patient education on safe storage and transport.

93. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989;84(11):1353-1357 — establishes a validated, standardised scale for withdrawal severity assessment, widely adopted as the clinical standard.

94. Specimen temperature verification and defined chain-of-custody procedures are established practice for preventing urine drug screening substitution and tampering in addiction treatment settings.

95. Day LW, Muthusamy VR, Collins J, Kushnir VM, Sultan S, Pannala R, et al. Multisociety guideline on reprocessing flexible GI endoscopes and accessories. Gastrointest Endosc. 2021;93(1):11-33 — requires a written reprocessing policy, model-specific manufacturer training, and documented staff competency prior to independent performance of high-level disinfection or sterilization.

96. Continuous pulse oximetry and capnography monitoring during procedural sedation, combined with specific, validated discharge criteria, are established practice in ambulatory endoscopy safety guidelines for detecting sedation-related respiratory compromise.

97. Failure to track biopsy and polypectomy specimens to a confirmed, communicated pathology result is identified as a specific and serious contributor to delayed colorectal cancer diagnosis in endoscopy patient safety literature, distinct in severity from general diagnostic test follow-up.

98. Institute for Safe Medication Practices. 2025-2026 Targeted Medication Safety Best Practices for Community Pharmacy. Horsham (PA): ISMP; 2025 — specifically addresses obtaining and using an accurate, current patient weight to verify weight-based medication dosing, applicable to medical offices and clinics.

99. Verification of legal decision-making authority, distinct from assumed authority based on who accompanies the child, is established practice in pediatric consent processes given the real variation in custody, guardianship, and family circumstances.

100. Active verification of vaccination status against the current recommended immunization schedule, rather than reliance on unverified parent report, is established practice for identifying and closing immunization gaps in pediatric ambulatory care.

101. WHO's guidance on financial protection in health systems identifies advance cost transparency as a determinant of genuine informed consent, a principle that applies with particular force when the patient has limited ability to seek a second opinion or negotiate after arrival.

102. Continuity of care across international transitions is identified in cross-border healthcare literature as a distinct risk point, with incomplete or inaccessible record transfer directly linked to preventable post-return complications.

103. Professional interpreter use is consistently associated with improved comprehension, informed consent quality, and clinical outcomes compared with ad hoc interpretation by untrained bilingual staff or family members.

104. Patient-reported experience research in medical tourism consistently identifies logistical coordination, not clinical quality alone, as a major determinant of overall satisfaction and perceived safety.

105. Post-operative complication tracking following international medical travel is identified in the medical tourism literature as a systemic gap, with most facilities lacking any mechanism to learn about complications that surface after the patient has returned home.

106. Medical travel facilitation literature identifies documentation delays and errors as a leading cause of care-seeking delay for international patients, with downstream clinical consequences for time-sensitive conditions.

107. Cross-border patient redress mechanisms are identified in international medical travel governance literature as a distinct requirement from domestic complaint processes, given the specific access barriers international patients face after returning home.

108. Medical tourism governance literature consistently identifies unregulated facilitator and agent networks as a distinct risk category, separate from the clinical quality of the treating facility itself.

109. Travel-associated antimicrobial resistance and infection risk is a documented, distinct category in infection prevention literature, with international medical travel specifically identified as a transmission risk pathway requiring targeted screening protocols.

110. Established international travel health guidance recommends against air travel for 10-14 days following major surgery given the combined risk of surgery and air travel for blood clots, including deep vein thrombosis and pulmonary embolism.

111. World Health Organization. Refugee and Migrant Health: Global Competency Standards for Health Workers. Geneva: WHO; 2021 — Competency Standard 3 states health workers have a responsibility not to engage minors to facilitate interpretation, given the associated significant risk, and identifies inaccuracy, information distortion, and compromised confidentiality as documented risks of family-member interpretation generally.

112. WHO Competency Standard 1 (Refugee and Migrant Health: Global Competency Standards for Health Workers, 2021) requires health workers to adapt practice to migration and displacement experiences, address trauma-informed care and psychosocial needs, and support continuity of care regardless of legal status.

113. WHO Competency Standards 2 and 4 (Refugee and Migrant Health: Global Competency Standards for Health Workers, 2021) require health workers to assess and support health system literacy as distinct from condition-specific understanding, and to actively verify genuine understanding through methods such as teach-back rather than assuming comprehension from silence.

114. WHO Competency Standard 5 requires engagement with broader social and community support services and effective handover of care that specifically includes cultural, language, and migration- and displacement-related considerations.

115. WHO Competency Standard 7 requires health workers to use evidence-informed guidelines specific to refugee and migrant health where they exist, recognise where the health needs of this population differ from the general population, and identify where evidence gaps remain.

116. WHO Competency Standards 8 and 9 (Refugee and Migrant Health: Global Competency Standards for Health Workers, 2021) require health workers to maintain structured awareness of their own biases and institutional discrimination's impact, and to engage in self-care within a supportive team environment addressing the wellbeing impacts of migration-context care.

117. WHO's Competency Standards explicitly distinguish these legal status categories throughout, noting that access to health care and legal entitlements vary meaningfully by status and by country, and that health workers need specific awareness of this rather than a single generalised assumption.

118. Equal standard of care and documentation regardless of immigration or legal status, without differential record-keeping practice, is established practice in international guidance on healthcare access for migrant and refugee populations.

119. WHO's explanatory notes for Competency Standard 1 specifically identify patient-held records — paper or electronic — updated regularly, as a key strategy for improving continuity of care given the mobility of refugee and migrant populations.

120. Follow-up systems accounting for housing and contact instability, distinct from standard address-and-phone-based recall systems, are established practice for maintaining continuity of care with transient and displaced patient populations.

Annex — ISO 9001:2015 Correlation Table

A single-place summary of every criterion's correlation to ISO 9001:2015, for anyone checking this standard's alignment without searching page by page. Criteria not listed here carry no ISO 9001:2015 correlation — this is stated honestly, not implied as a gap in the standard itself; many patient-safety and dignity criteria simply fall outside a quality-management-system standard's scope.

Index

Alphabetical, correlated to page number.

A

Adapted 85, 97, 99, 101, 256

Aerosol 105, 106

Aftercare 77, 237

ALARA 108, 165, 166

Amalgam 111, 112

Anaphylaxis 138, 139, 162

B

Behavioral health 206, 210

Biopsy 182, 183, 188, 223, 224

C

Calibration 33, 39, 150

Cataract 168, 169, 170

Chaperone 61, 62

Chemotherapy 134, 135, 136, 137

Cleanliness 34, 35, 66

Complaints 81, 82, 97, 245

Confidentiality 88, 89, 255

Continual improvement 100, 101

Continuity of care 50, 56, 236, 256, 257, 271, 272, 274

Contrast media 161, 162, 179, 180

Cross-border 56, 236, 246, 250, 271

Cryotherapy 184, 185

D

Decision-maker 228, 229

Dental 103, 104, 105, 106, 107, 108, 109, 110, 111, 112

Dialysis water 141, 142

Dignity 62, 63

Diversion control 212, 213

Dose escalation 193, 194

E

Embryo transfer 154, 155

Embryology 150, 151, 153, 159

Endophthalmitis 168, 169

Endoscope reprocessing 219, 220

Equipment maintenance 33, 36, 39

Extravasation 136, 137

F

Facilitator 247, 248

Fire safety 36, 72, 73

Follow-up 60, 79, 80, 183, 189, 205, 206, 224, 241, 273, 274

G

Governance 85, 87, 95, 246, 248

H

Hand hygiene 47, 48, 144

Hormone 125, 126, 127, 128, 129, 130, 152

I

Immunotherapy 191, 192, 193, 194, 196

Incident reporting 92, 93

Informed consent 110, 157, 234, 238

Infusion reaction 138, 139

Injectable 114, 115, 116, 117, 121

Interpreter 237, 238, 254

Intradialytic 145, 146

ISO 9001 3, 97, 99, 101

L

Leadership 37, 84, 85, 96

Legal status 257, 261, 267, 268, 269, 270

M

Medical tourism 236, 238, 240, 242, 247, 248, 252

Medication safety 208, 227

Melanoma 183, 189

Micro 4, 141, 142, 250

Migrant health 255, 257, 259, 262, 263, 266

N

Non-discrimination 63, 64

O

Ovarian stimulation 152, 153

P

Patient selection 115, 121, 202, 203

Pediatric 135, 227, 229, 231

Peptide 125, 126, 127, 128, 129, 130

Phototherapy 186, 187

Physician oversight 127, 152, 153

Point-of-care testing 40, 41

Polyp 223, 224

Procedural sedation 221, 222

Psychotropic 207, 208

Q

Quality objectives 98, 99

R

Radiation exposure 108, 165, 166

Reception 16, 17, 23

Referral 55, 56, 57, 58, 80, 188

Refugee 255, 257, 259, 260, 261, 262, 263, 266, 267, 268, 270, 271, 272, 274

Resuscitation 70, 71

S

Self-assessment 10, 199

Solo practitioner 4, 85, 97, 99, 101

Sterilization 103, 104, 220

Suspicious lesion 188, 189

T

U

V

Vaccination 230, 231

Vascular access 143, 144, 163, 164

Vascular occlusion 115, 118, 119

Venous thromboembolism 198, 199, 251

VTE 198, 199

W

Water safety 36, 142

Weight-based dosing 226, 227

Witnessing protocol 158, 159